MS
Mizuho Securities Portfolio holdings
AUM
$27.7M
This Quarter Return
+1.11%
1 Year Return
+23.85%
3 Year Return
+192.43%
5 Year Return
+10.18%
10 Year Return
–
AUM
$523M
AUM Growth
+$523M
(+8.4%)
Cap. Flow
+$38.5M
Cap. Flow
% of AUM
7.35%
Top 10 Holdings %
Top 10 Hldgs %
91.36%
Holding
214
New
22
Increased
91
Reduced
63
Closed
8
Top Buys
| 1 |
Micron Technology
MU
|
$4.5M |
| 2 |
Palo Alto Networks
PANW
|
$3.3M |
| 3 |
Walt Disney
DIS
|
$2.87M |
| 4 |
Netflix
NFLX
|
$2.79M |
| 5 |
XYZ
Block, Inc.
XYZ
|
$2.63M |
Top Sells
| 1 |
JD.com
JD
|
$3.72M |
| 2 |
Alibaba
BABA
|
$1.47M |
| 3 |
Takeda Pharmaceutical
TAK
|
$1.27M |
| 4 |
Microsoft
MSFT
|
$885K |
| 5 |
Cisco
CSCO
|
$712K |
Sector Composition
| 1 | Consumer Discretionary | 86.71% |
| 2 | Technology | 6.72% |
| 3 | Communication Services | 2.02% |
| 4 | Healthcare | 1.61% |
| 5 | Financials | 1.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Travelers Companies
TRV
$61B
| $10K | ﹤0.01% |
68
-1
| -1% | -$147 |
|
102
Verizon
VZ
$185B
| $9K | ﹤0.01% |
166
| – | – |
|
103
DocuSign
DOCU
$14.9B
| $8K | ﹤0.01% |
28
| – | – |
|
104
AbbVie
ABBV
$374B
| $8K | ﹤0.01% |
70
-9
| -11% | -$1.03K |
|
105
Ball Corp
BALL
$13.9B
| $8K | ﹤0.01% |
100
-1,150
| -92% | -$92K |
|
106
Blackstone
BX
$132B
| $8K | ﹤0.01% |
81
| – | – |
|
107
Domino's
DPZ
$15.8B
| $8K | ﹤0.01% |
17
+1
| +6% | +$471 |
|
108
Main Street Capital
MAIN
$5.87B
| $8K | ﹤0.01% |
183
+131
| +252% | +$5.73K |
|
109
Merck
MRK
$213B
| $8K | ﹤0.01% |
102
+1
| +1% | +$78 |
|
110
Cloudflare
NET
$72B
| $8K | ﹤0.01% |
78
-3
| -4% | -$308 |
|
111
PepsiCo
PEP
$207B
| $8K | ﹤0.01% |
56
+1
| +2% | +$143 |
|
112
Roku
ROKU
$14B
| $8K | ﹤0.01% |
18
-5
| -22% | -$2.22K |
|
113
Target
TGT
$41.9B
| $8K | ﹤0.01% |
34
| – | – |
|
114
Thermo Fisher Scientific
TMO
$183B
| $8K | ﹤0.01% |
15
| – | – |
|
115
Walmart
WMT
$779B
| $8K | ﹤0.01% |
55
-1,229
| -96% | -$179K |
|
116
Bristol-Myers Squibb
BMY
$96.4B
| $7K | ﹤0.01% |
99
+2
| +2% | +$141 |
|
117
Boston Scientific
BSX
$158B
| $7K | ﹤0.01% |
155
+1
| +0.6% | +$45 |
|
118
Costco
COST
$416B
| $7K | ﹤0.01% |
19
+1
| +6% | +$368 |
|
119
CRISPR Therapeutics
CRSP
$4.79B
| $7K | ﹤0.01% |
45
-4
| -8% | -$622 |
|
120
CVS Health
CVS
$93.6B
| $7K | ﹤0.01% |
81
-1
| -1% | -$86 |
|
121
DoorDash
DASH
$104B
| $7K | ﹤0.01% |
41
-1
| -2% | -$171 |
|
122
Danaher
DHR
$145B
| $7K | ﹤0.01% |
27
-1
| -4% | -$259 |
|
123
Estee Lauder
EL
$32.5B
| $7K | ﹤0.01% |
20
-2
| -9% | -$700 |
|
124
Gilead Sciences
GILD
$140B
| $7K | ﹤0.01% |
99
+3
| +3% | +$212 |
|
125
HCA Healthcare
HCA
$94.9B
| $7K | ﹤0.01% |
31
| – | – |
|